Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting 10 August 2020
Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting
10 August 2020
Similar to Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting 10 August 2020
Similar to Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting 10 August 2020 (20)
Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting 10 August 2020
1. Inception Workshop
Wayne Jiang, PhD
IR-4 Project
Michigan State University
jiangwa@msu.edu
Lab Training Overview
and Equipment
3. • Training Dates
Mon-Fri, Aug 10-14, 2020 (5 days)
3 Hours / day
A coffee break 10-15 min/session
Lab Training
4. • Good Laboratory Practices (GLP)
• Protocol (Lab portion)
• Standard Operating Procedures (SOP)
• Amendments and deviations
Training Contents
5. • Sample shipping, sample receipt,
grinding, storage and disposal
• Analytical Reference Substance
• Instrument analysis
• Data review and QC
Training Contents
6. • Freezers and temperature monitoring
• Grinders
• Pipets, Shakers, SPE
• Analytical instrumentation
• LC-MS/MS
Laboratory Equipment
7. Laboratory Equipment
Country Crop Chemical Chemical Chemical LC-
MS/MS
GC-MS or
GC-MS/MS
GC-
ECD
GC-
FID
Indonesia
Malaysia
Sri Lanka
Thailand
Chili
pepper
Abamectin Chlorpyrifos Methomyl Yes No No No
Acephate Diazinon Prochloraz Yes Yes Yes? No
Acetamiprid Fipronil Profenophos Yes Yes Yes? No
Amitraz Imidacloprid Yes Yes Yes? No
Bangladesh
Nepal
Pakistan
Sri Lanka
Greens Acetamiprid Yes Yes Yes? No
Imidacloprid Yes No No No
Malathion Yes Yes Yes? No
Laos
Cambodia
Basil Chlorpyrifos Yes Yes Yes? No
Cypermethrin Yes Yes Yes? No
Vietnam Dragon
fruit
Metalaxyl Yes Yes Yes? No
Hexaconazole Yes Yes Yes? No
Propiconazole Yes Yes Yes? No
Cambodia Rice Tricyclazole Yes Yes Yes? No
9. Lab GLP Training
New York Time, Monday - Friday, August
10-14, 2020 (Total 5 days)
• Session 1: 6:00 AM - 7:00 AM
• Coffee Break: 7:00 AM – 7:20 AM
• Session 2: 7:20 AM – 8:20 AM
• Questions: 8:20 AM – 8:50 AM
12. GLP TRAINING
Wayne Jiang, PhD
IR-4, Michigan State University, jiangwa@msu.edu
Michael Braverman, PhD
IR-4 Headquarters, Rutgers University
13. General Terms
• GLP Good Laboratory Practices
• GMP Good Manufacturing Practices
• GCP Good Clinical Practices
14. • Protocol (or Work Plan)
A document which clearly indicates the objectives and
methods for the conduct of the study
• SOPs
Set of Standard Operating Procedures
• Working Methods
Individual working methods
General Terms
15. General Terms
• EPA
Environmental Protection Agency
• FDA
Food and Drug Administration
• OECD
Organization for Economic
Co-operation and Development
16. General Terms
• SD
Study Director
• FRD and LRD
Field Research Director
Laboratory Research Director
• QA
Quality Assurance
17. Definitions
• Good Laboratory Practice
– Good Laboratory Practice (GLP) is a quality
system with the organizational process and
the conditions under which non-clinical
health and environmental safety studies are
planned, performed, monitored, recorded,
archived and reported.
18. Definitions
• Nonclinical laboratory study
– In vivo or in vitro experiments in which test
articles are studied prospectively in test systems
under laboratory conditions to determine their
safety. The term does not include studies
utilizing human subjects or clinical studies or field
trials in animals. The term does not include basic
exploratory studies carried out to determine
whether a test article has any potential utility or to
determine physical or chemical characteristics of
a test article.
– 21 CFR Part 58.3(d)
19. Definitions
• Sponsor
– A person who initiates and supports, by
provision of financial or other resources, a
nonclinical laboratory study;
– A person who submits a nonclinical study to
the FDA in support of an application for a
research or marketing permit; or
– A testing facility, if it both initiates and actually
conducts the study.
21 CFR Part 58.3(f)(1)(2)(3)
20. Definitions
• Sponsor
– A person who initiates and supports, by
provision of financial or other resources, a
study;
– A person who submits a study to the EPA in
support of an application for a research or
marketing permit; or
– A testing facility, if it both initiates and actually
conducts the study.
40 CFR 160.3 (7)
21. Definitions
• Sponsor
• Sponsor means an entity which
commissions, supports and/or submits a
non-clinical health and environmental
safety study.
– OECD GLP
22. Definitions
• Testing Facility (FDA)
– A person who actually conducts a nonclinical
laboratory study, i.e., actually uses the test article in a
test system. 21 CFR Part 58.3(g)
• Testing Facility (EPA)
– Testing facility means a person who actually conducts
a study, i.e., actually uses the test substance in a test
system. ``Testing facility'' encompasses only those
operational units that are being or have been used to
conduct studies. 40 CFR Part 160 (2.2)
23. Definitions
• Testing Facility (OECD)
- Test facility means the persons, premises and
operational unit(s) that are necessary for conducting
the non-clinical health and environmental safety study.
OECD GLP 2.2
24. Definitions
• Quality Assurance Unit (QAU)
– Any person or organizational element, except the
study director, designated by testing facility
management to perform the duties relating to quality
assurance of nonclinical laboratory studies.
– 21 CFR Part 58.3(l)
• Quality Assurance Unit (QAU)
– Quality assurance unit means any person or
organizational element, except the study director,
designated by testing facility management to perform
the duties relating to quality assurance of the studies.
– 40 CFR Part 160.105(a)
25. Definitions
• Quality Assurance Unit (QAU)
Quality Assurance Programme means a defined system,
including personnel, which is independent of study conduct
and is designed to assure test facility management of
compliance with these Principles of Good Laboratory
Practice. OECD GLP 2.2(8)
26. Definitions
• Standard Operating Procedures
– Documented procedures which describe how
to perform tests or activities normally not
specified in detail in study plans or test
guidelines 40 CFR 160.16(3)
27. Definitions
• Standard Operating Procedures
SOPs means documented procedures which
describe how to perform tests or activities normally
not specified in detail in study plans or test
guidelines. OECD GLP 2.2 (9)
28. Definitions
• Study Director (SD)
– The individual responsible for the overall
conduct of a nonclinical laboratory study.
– 21 CFR Part 58.3(m)
– Study director means the individual
responsible for the overall conduct of a study.
40 CFR Part 105(3)
29. Definitions
• Study Initiation Date
The date the protocol is signed by study director
• Term defined in FDA, EPA FIFRA, EPA TSCA, OECD GLPs
• Experimental Start Date
– The first date the test substance is applied to
the test system.
• Term defined in EPA FIFRA, EPA TSCA GLPs
• Experimental Starting Date
– The date on which the first study specific data
are collected.
• Term defined in OECD GLPs
30. Definitions
• Study Completion Date
– The date the final report is signed by SD
• Term defined in FDA, EPA FIFRA, EPA TSCA, OECD GLPs
• Experimental Termination Date
– The last date on which data are collected
directly from the study
• Term defined in EPA TSCA, EPA FIFRA GLPs
• Experimental Completion Date
– The last date on which data are collected from
the study
• Term defined in OECD GLPs
31. • GLPs are regulations that are intended
to ensure the quality and integrity of the
data in a nonclinical laboratory study.
32. GLPs are the LAW!
What are GLPs?
GLPs are regulations that are intended
to ensure the quality and integrity of the
data in a laboratory study.
33.
34. Basic Information
GLPs deal with:
– Planning
– Performance
– Monitoring
– Recording
– Reporting
GLPs do NOT:
Attempt to
regulate science
Ensure
“good science”
35. Basic Information
• Responsibility for establishing the safety and efficacy of
human and veterinary drugs and devices, and the safety
of food and color additives is placed on the sponsor
(manufacturer) of the regulated product.
• Public agencies (FDA, EPA, OECD, etc) are responsible
for reviewing the sponsor’s test results and determine if
they demonstrate the product’s safety and efficacy.
• Only when the agencies are satisfied that safety and
efficacy have been established adequately is the
marketing of the product permitted.
36. Nonclinical laboratory studies
GLP is needed for: GLP is not needed for:
• Nonclinical safety studies of
development of drugs
• Agricultural pesticide
development
• Development of toxic
chemicals
• Food control (food
additives)
• Test of substance with
regard to explosive hazards
• Basic scientific research
• Studies to develop new
analytical methods (but
Method Validation is GLP
required)
• Chemical tests used to
derive the specifications of a
marketed food product
37. International GLPs
• Generally studies at will
are conducted under
GLPs from US, Japan,
Australia, etc. and/or
OECD
– Some protocols list various
GLPs
– Formal claims of
compliance with other
national regulations should
be avoided, if possible
38. KEYWORDS
• Testing facility
• Study Director
• FFDCA
• FIFRA
• NAFTA
• Sponsor
• Raw data
• Principal Investigator
• QA/QAU
• SOP
• Master Schedule
• Study plan
• Amendment
• Deviation
40. IR-4 Project
Since 1963 IR-4 has been a US
government funded research program
to facilitate registration of sustainable
pest management technology for
specialty crops and minor uses
http://ir4project.org
USDA Interregional Research Project Number 4
44. IR-4 Protocol
Every page contains
PR No.
Objectives
All Proposed Dates and Sites
Study Director’s Signature, Date
Sponsor
Study Director’s Initial
Study Director’s Name
45. ASR Page
Testing Facility
Study Director
Sponsor
Study Initiation Date
Experimental Termination Date
Title of Study
PR Number
47. International Activities
• Data-50 reports submitted to Canada’s
JMPR/Reg. Authorities
• Leadership-NAFTA, OECD, and Codex CCPR
• Capacity Building w/FAS in Africa, Asia, Central
and S. America
• Global Residue Study
• Global Minor Use Summit 2
• Capacity Building
48. IR-4 Activities
• Food Use Program
• Bio and Organic pesticides
• Ornamental Program
• Public Health
49. IR-4 Project Infrastructure - Pesticide Residue work
90 studies/550 field trials
IR-4 HQ
IR-4 Regional Program Office
State Satellite Labs
State Field Research Centers/Food Use
Hawaii =ARS Labs
ARS Field Research Centers
State Field Research Centers/ Ornamentals and
Non-food Use
ARS Field Research Centers
ARS Field Research Centers